Prostate Screen Australia is Australia’s first and only prostate cancer testing group. Prostate Screen Australia provides men between 40 – 70 with prostate cancer testing in a clinic environment. Prostate cancer testing at Prostate Screen Australia requires no referral and only costs $50* out of pocket.
Read more…
The New England Journal of Medicine today published the latest results from the European Randomised Study of Screening for Prostate Cancer (ERSPC) that commenced in 1991. Since 1991, investigators led by prostate cancer screening expert: Dr Fritz H Schroder have
Read more…
Did you know that Prostate Cancer is Australia’s most common male cancer and the second leading cause of cancer death? Today, more men will die from prostate cancer than women will of breast cancer. The solution however is as simple
Read more…
The inaugural ‘Lunch for the Lads’ was organised by Major League Corporate Marketing and held on Friday the 25th of May at ‘The Strand’ – Queensland Rugby Club. The lunch was attended by over 200 guests who were there to
Read more…
A report published in the June edition of the ‘Medical Insurance Group Australia’ (MIGA) bulletin raised concerns that General Practitioners (GPs) risk being sued for the delayed diagnosis of prostate cancer that has arisen out of the conflicting guidance on
Read more…
A study recently published in the Journal titled Nutrition and Cancer titled ‘Tea Consumption and the Risk of Overall and Grade Specific Prostate Cancer: a Large Prospective Cohort Study of Scottish Men’ examined the effects of tea drinking on the
Read more…
A new blood test is now available for use in prostate cancer testing, known as the ‘Prostate Health Index’ (phi). A marker for prostate cancer was recently identified known as truncated proPSA (p2PSA). p2PSA circulates in the blood as a
Read more…
The U.S. Preventive Services Task Force (USPSTF) recently released recommendations regarding prostate cancer testing by way of the Prostate Specific Antigen (PSA) blood test in their report titled “Screening for Prostate Cancer: A Review of the Evidence for the U.S
Read more…
Site by 
Site Information